Gritstone bio, Inc.
GRTSDelisted Mar 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001656634
Gritstone bio, Inc. was delisted on Mar 5, 2025; its insiders filed their last Form 4 on Apr 8, 2025; 56 institutions reported holding it in 13F filings for Q3 2024, worth $20.7M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Gritstone bio, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 79 | 1 | 91 | +13 |
| Shares | 33.5M | 47.5K | 44.1M | +10.7M (+32.0%) |
| Value | $86.0M | $122.0K | $152.1M | +$66.2M (+77.1%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (24)
Institutions that held Gritstone bio, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (11)
Institutions that held Gritstone bio, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Connor, Clark & Lunn Investment Management Ltd. | 123,822 | $318.0K |
| Renaissance Technologies LLC | 79,500 | $204.0K |
| Ergoteles LLC | 58,700 | $151.0K |
| Public Employees Retirement System of Ohio | 57,700 | $148.0K |
| XTX Topco Ltd | 50,517 | $130.0K |
| Deep Track Capital, LP | 45,500 | $117.0K |
| Ameriprise Financial Inc | 40,967 | $106.0K |
| Occudo Quantitative Strategies LP | 40,552 | $104.0K |
| Schonfeld Strategic Advisors LLC | 31,200 | $80.0K |
| LMR Partners LLP | 15,240 | $39.0K |
| Spears Abacus Advisors LLC | 11,809 | $30.0K |
Not filed for Q4 2022 yet (1)
Institutions that held Gritstone bio, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| ACT Capital Management, LLC | 47,500 | $122.0K |